587 related articles for article (PubMed ID: 28411578)
1. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice.
Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M
Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
Int Immunopharmacol; 2016 Nov; 40():41-49. PubMed ID: 27580414
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.
Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M
J Theor Biol; 2018 Apr; 442():1-10. PubMed ID: 29337259
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin.
Suk Lee Y; Davila E; Zhang T; Milmoe HP; Vogel SN; Bromberg JS; Scalea JR
Innate Immun; 2019 Jan; 25(1):46-59. PubMed ID: 30782043
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
8. Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation.
Otsubo D; Yamashita K; Fujita M; Nishi M; Kimura Y; Hasegawa H; Suzuki S; Kakeji Y
Anticancer Res; 2015 Aug; 35(8):4425-31. PubMed ID: 26168482
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells Contribute to Susceptibility to
Onyilagha C; Kuriakose S; Ikeogu N; Jia P; Uzonna J
J Immunol; 2018 Jul; 201(2):507-515. PubMed ID: 29898961
[TBL] [Abstract][Full Text] [Related]
10. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
11. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
13. Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice.
Pilot T; Fratti A; Thinselin C; Perrichet A; Demontoux L; Limagne E; Derangère V; Ilie A; Ndiaye M; Jacquin E; Garrido C; Ghiringhelli F; Chalmin F; Rébé C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385145
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
[TBL] [Abstract][Full Text] [Related]
15. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
18. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
[TBL] [Abstract][Full Text] [Related]
19. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner.
Katayama Y; Tachibana M; Kurisu N; Oya Y; Terasawa Y; Goda H; Kobiyama K; Ishii KJ; Akira S; Mizuguchi H; Sakurai F
J Immunol; 2018 Apr; 200(8):2987-2999. PubMed ID: 29555782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
